Head-to-head · computed 2026-08-11
Hims & Hers vs Yucca Health
Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping. Yucca Health: Yucca pairs no-membership pricing with dose-flat rates: $146/month semaglutide and $258/month tirzepatide, both all-in.
Tirzepatide
| Hims & Hers | Yucca Health | |
|---|---|---|
| All-in maintenance | $548/mo | $258/mo |
| Best plan rate | $548/mo | $258/mo |
| 12-month total | $6,576 | $3,096 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Yucca Health's $258 a month undercuts Hims & Hers's $548 by $290 a month at the 10 mg/wk maintenance basis — $3,480 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's tirzepatide ladder runs $548 a month billed monthly. Yucca Health's runs $258 a month billed monthly. On the twelve-month basis Yucca Health's $3,096 beats Hims & Hers's $6,576 by $3,480 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Hims & Hers | Yucca Health | |
|---|---|---|
| All-in maintenance | $453/mo | $146/mo |
| Best plan rate | $453/mo | $146/mo |
| 12-month total | $5,436 | $1,752 |
| Status | Reported · 2026-08-11 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Yucca Health's $146 a month undercuts Hims & Hers's $453 by $307 a month at the 2.4 mg/wk maintenance basis — $3,684 across a year. Yucca Health's figure is provider-stated (captured 2026-08-05) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Hims & Hers's semaglutide ladder runs $453 a month billed monthly. Yucca Health's runs $146 a month billed monthly. On the twelve-month basis Yucca Health's $1,752 beats Hims & Hers's $5,436 by $3,684 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Yucca Health carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, Yucca Health is dose-flat — the price survives titration — while Hims & Hers's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
Yucca Health
- MembershipNone
- Dose policyDose-flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner 503A pharmacies
What our desk is watching on each
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Yucca Health: Provider-stated from published pages; checkout capture pending.
Questions people ask
Is Hims & Hers or Yucca Health cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Hims & Hers vs Yucca Health miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Hims & Hers and Yucca Health cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $6,576 at Hims & Hers and $3,096 at Yucca Health — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Hims & Hers · Yucca Health. Official sites: Hims & Hers ↗ · Yucca Health ↗. Nothing here is medical advice.